GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Cash Flow from Financing

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Cash Flow from Financing : $0.00 Mil (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2022, Arbor Rapha Capital Bioholdings I paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Arbor Rapha Capital Bioholdings I spent $0.00 Mil on financial activities for the three months ended in Sep. 2022.


Arbor Rapha Capital Bioholdings I Cash Flow from Financing Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I Cash Flow from Financing Chart

Arbor Rapha Capital Bioholdings I Annual Data
Trend Dec21
Cash Flow from Financing
-

Arbor Rapha Capital Bioholdings I Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cash Flow from Financing Get a 7-Day Free Trial - - - - -

Arbor Rapha Capital Bioholdings I Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Arbor Rapha Capital Bioholdings I's Cash from Financing for the fiscal year that ended in Dec. 2021 is calculated as:

Arbor Rapha Capital Bioholdings I's Cash from Financing for the quarter that ended in Sep. 2022 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arbor Rapha Capital Bioholdings I  (NAS:ARCK) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Arbor Rapha Capital Bioholdings I's issuance of stock for the three months ended in Sep. 2022 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Arbor Rapha Capital Bioholdings I's repurchase of stock for the three months ended in Sep. 2022 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Arbor Rapha Capital Bioholdings I's net issuance of debt for the three months ended in Sep. 2022 was $0.00 Mil. Arbor Rapha Capital Bioholdings I received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Arbor Rapha Capital Bioholdings I's net issuance of preferred for the three months ended in Sep. 2022 was $0.00 Mil. Arbor Rapha Capital Bioholdings I paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Arbor Rapha Capital Bioholdings I's cash flow for dividends for the three months ended in Sep. 2022 was $0.00 Mil. Arbor Rapha Capital Bioholdings I received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Arbor Rapha Capital Bioholdings I's other financing for the three months ended in Sep. 2022 was $0.00 Mil. Arbor Rapha Capital Bioholdings I received $0.00 Mil on other financial activities.


Arbor Rapha Capital Bioholdings I Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Traded in Other Exchanges
N/A
Address
333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553
Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Ralph Mack director 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin director, officer: Chief Strategy Officer C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio officer: Chief Financial Officer C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone officer: Treasurer C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly officer: Secretary & Vice President C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker director C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin director C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines